Five Prime Therapeutics, Inc. FPRX
Day range unavailable
52-week range unavailable
FPRX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
Not available USD
FY 2020 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Capital expenditure is reported net of asset sales as an inflow for some periods; free cash flow is not shown for them.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Missing observations.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2020 | 2020-12-31 | Not available | Not available | Not available |
| FY 2019 | 2019-12-31 | -115,642,000 | 18,203,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -133,845,000 | -16,732,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -117,113,000 | -34,401,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -82,712,000 | -369,384,000 | -128.85% |
| FY 2015 | 2015-12-31 | 286,672,000 | 273,050,000 | 2004.48% |
| FY 2014 | 2014-12-31 | 13,622,000 | 39,759,000 | Not meaningful |
| FY 2013 | 2013-12-31 | -26,137,000 | -7,003,000 | Not meaningful |
| FY 2012 | 2012-12-31 | -19,134,000 | -41,451,000 | -185.74% |
| FY 2011 | 2011-12-31 | 22,317,000 | 33,454,000 | Not meaningful |
| FY 2010 | 2010-12-31 | -11,137,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:02:52.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.